EARNEST Partners’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8
| Closed | -$198 | – | 310 |
|
|
2023
Q3 | $198 | Hold |
8
| – | – | ﹤0.01% | 1149 |
|
|
2023
Q2 | $227 | Hold |
8
| – | – | ﹤0.01% | 1151 |
|
|
2023
Q1 | $184 | Hold |
8
| – | – | ﹤0.01% | 1154 |
|
|
2022
Q4 | $225 | Hold |
8
| – | – | ﹤0.01% | 1153 |
|
|
2022
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 1121 |
|
|
2022
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 1143 |
|
|
2022
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 1150 |
|
|
2021
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 1161 |
|
|
2021
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 1164 |
|
|
2021
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 1170 |
|
|
2021
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 1174 |
|
|
2020
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 1180 |
|
|
2020
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 1160 |
|
|
2020
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 1147 |
|
|
2020
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 1109 |
|
|
2019
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 1165 |
|
|
2019
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 1156 |
|
|
2019
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 1168 |
|
|
2019
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 1077 |
|
|
2018
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 1179 |
|
|
2018
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 1089 |
|
|
2018
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 1097 |
|
|
2018
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 1071 |
|
|
2017
Q4 | $0 | Buy |
+8
| New | +$503 | ﹤0.01% | 1194 |
|
|
2017
Q1 | – | Sell |
-8
| Closed | – | – | 249 |
|
|
2016
Q4 | $0 | Buy |
+8
| New | +$420 | ﹤0.01% | 1142 |
|
Other funds holding AGIO
FCM
BG
AC
RSCM
EAM